fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

The right diet can safeguard against acute kidney injury

Written by | 23 Mar 2022

A research team led by Professor Dr Roman-Ulrich Müller has established that four out of six different nutritional strategies prevent acute kidney injury in the mouse model. Furthermore,… read more.

Cannabis use could cause harmful drug interactions

Written by | 17 Dec 2021

Using cannabis alongside other drugs may come with a significant risk of harmful drug-drug interactions, new research by scientists at Washington State University suggests. The researchers looked at… read more.

Transplants for alcohol-related liver inflammation surge during pandemic

Written by | 30 Nov 2021

The increased number of deceased donor liver transplants related to alcoholic hepatitis — up more than 50 percent over predicted numbers — was associated with rising alcohol sales…. read more.

Pesticide linked to chronic kidney disease

Written by | 28 Nov 2021

A commonly available pesticide has been associated with an increased risk of chronic kidney disease (CKD) in a University of Queensland study. Researchers analysed links between pesticide exposure… read more.

What you need to know about urinary tract infections

Written by | 19 Nov 2021

New study finds women who experience recurrent UTIs are unhappy with limited management options for the painful condition. Despite the prevalence of the painful condition, women are fearful and… read more.

Kidney cancer: children in the UK and Ireland diagnosed late

Written by | 14 Nov 2021

Children with kidney cancers in the UK and Ireland are diagnosed with larger and more advanced tumours than in other Western European countries, according to research presented at… read more.

European Commission approves Evrenzoto treat adult patients with symptomatic anemia associated with chronic kidney disease – Astellas + FibroGen Inc.

Written by | 1 Sep 2021

Astellas Pharma Inc.and FibroGen, Inc. announced that the European Commission (EC) has approved Evrenzo (roxadustat) for the treatment of adult patients with symptomatic anemia associated with chronic kidney… read more.

FibroGen receives Complete Response Letter from the FDA for roxadustat for anemia of chronic kidney disease – FibroGen + AstraZeneca

Written by | 22 Aug 2021

The FDA has issued a complete response letter (CRL) regarding the New Drug Application (NDA) for roxadustat for the treatment of anaemia of chronic kidney disease (CKD), in… read more.

Study identifies a major role for immune cells called natural killer cells in organ rejection

Written by | 1 Aug 2021

Immune cells called natural killer cells contribute to organ rejection after transplantation because they miss “self” proteins on donor cells, according to a study appearing in an upcoming… read more.

Depressive symptoms linked to rapid kidney function decline

Written by | 31 Jul 2021

In a study of adults with normal kidney function, those who had frequent depressive symptoms were more likely to later experience a rapid decline in kidney function. The… read more.

GSK announces positive headline results from five phase III studies of daprodustat for patients with anaemia due to chronic kidney disease

Written by | 28 Jul 2021

GlaxoSmithKline plc announced positive headline results from five studies of the Phase III ASCEND programme, evaluating the efficacy and safety profile of daprodustat, an investigational oral hypoxia-inducible factor… read more.

Antibody-targeted immunotoxins could help treat liver fibrosis

Written by | 22 Jul 2021

University of California – San Diego In mouse models of human disease, immunotoxins targeting the protein mesothelin prevent liver cells from producing collagen, a precursor to fibrosis and… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.